NRl 577/l NR577l Midterml Exam:l Primaryl
Carel Managementl ofl Adolescentsl andl
Adultsl Reviewl (Latestl 2026/l 2027l
Update)l |l Qsl &l As|l Gradel A|l 100%l
Correctl (Verifiedl Answers)-l Chamberlain
QUESTION
Whatl arel thel 5l Psl ofl sexuall history?
Answer:
Partners,l Practices,l Protectionl froml STDs,l Pastl Historyl ofl STDs,l Preventionl ofl
Pregnancy.
QUESTION
Whatl isl thel mostl commonl abnormall findingl inl Papl smears?
Answer:
Atypicall squamousl cells.
QUESTION
Whatl doesl atypicall glandularl celll findingl inl Papl smearsl indicate?
Answer:
Commonl inl womenl agesl 40-69;l 1/3l arel associatedl withl pre-malignancyl orl malignancy.
QUESTION
Whatl isl thel recommendationl forl low-gradel glandularl celll findings?
Answer:
Usuallyl causedl byl low-riskl HPVl infection.
,QUESTION
Whatl isl thel significancel ofl high-gradel squamousl celll findingsl inl Papl smears?
Answer:
Associatedl withl premalignancyl andl malignancy;l referl forl colposcopy.
QUESTION
Whatl arel Tierl 1l contraceptives?
Answer:
Intrauterinel devices,l includingl copper-bearingl andl levonorgestrel-releasingl devices.
QUESTION
Whatl isl thel mechanisml ofl actionl forl intrauterinel devices?
Answer:
Theyl producel anl inflammatoryl responsel tol decreasel pregnancy.
QUESTION
Whatl isl thel lifespanl ofl copperl devicesl usedl forl contraception?
Answer:
10l years.
QUESTION
Whatl isl thel lifespanl ofl hormonel devicesl usedl forl contraception?
Answer:
3-5l years.
,QUESTION
Whatl arel thel benefitsl ofl usingl hormonall contraceptives?
Answer:
Highlyl effective,l lastsl 5-10l years,l andl reducesl menstruall flow.
QUESTION
Whatl isl Depotl Medroxyprogesteronel Acetatel (DMPA)l commonlyl knownl as?
Answer:
Depo-Provera.
QUESTION
Whatl arel thel primaryl actionsl ofl Depo-Provera?
Answer:
Preventsl LH,l inhibitsl ovulation,l thickensl cervicall mucus,l andl causesl endometriall atrophy.
QUESTION
Whatl isl al significantl sidel effectl ofl Depo-Provera?
Answer:
Lossl ofl bonel minerall densityl (blackl boxl warning;l avoidl usel forl morel thanl 2l years)l
andl delayedl returnl ofl fertility.
QUESTION
Whatl isl thel durationl ofl effectivenessl forl Depo-Provera?
Answer:
Lastsl 3l months.
QUESTION
, Whatl isl thel agel rangel forl bienniall mammographyl screeningl forl womenl atl averagel risk?
Answer:
Agesl 50-74l years.
QUESTION
Whatl typel ofl mammographyl screeningl isl recommendedl forl womenl agesl 40-49l withl
averagel risk?
Answer:
Individualizedl mammographyl screening.
QUESTION
Whatl isl thel recommendationl regardingl breastl self-examsl forl womenl ofl anyl age?
Answer:
Insufficientl evidencel tol recommendl duel tol associatedl risks.
QUESTION
Atl whatl agel shouldl cervicall screeningl start?
Answer:
Agel 21.
QUESTION
Whatl isl thel cervicall cytologyl screeningl recommendationl forl womenl agesl 21-65?
Answer:
Everyl 3l years.
QUESTION
Isl HPVl co-testingl recommendedl forl womenl underl 30?
Carel Managementl ofl Adolescentsl andl
Adultsl Reviewl (Latestl 2026/l 2027l
Update)l |l Qsl &l As|l Gradel A|l 100%l
Correctl (Verifiedl Answers)-l Chamberlain
QUESTION
Whatl arel thel 5l Psl ofl sexuall history?
Answer:
Partners,l Practices,l Protectionl froml STDs,l Pastl Historyl ofl STDs,l Preventionl ofl
Pregnancy.
QUESTION
Whatl isl thel mostl commonl abnormall findingl inl Papl smears?
Answer:
Atypicall squamousl cells.
QUESTION
Whatl doesl atypicall glandularl celll findingl inl Papl smearsl indicate?
Answer:
Commonl inl womenl agesl 40-69;l 1/3l arel associatedl withl pre-malignancyl orl malignancy.
QUESTION
Whatl isl thel recommendationl forl low-gradel glandularl celll findings?
Answer:
Usuallyl causedl byl low-riskl HPVl infection.
,QUESTION
Whatl isl thel significancel ofl high-gradel squamousl celll findingsl inl Papl smears?
Answer:
Associatedl withl premalignancyl andl malignancy;l referl forl colposcopy.
QUESTION
Whatl arel Tierl 1l contraceptives?
Answer:
Intrauterinel devices,l includingl copper-bearingl andl levonorgestrel-releasingl devices.
QUESTION
Whatl isl thel mechanisml ofl actionl forl intrauterinel devices?
Answer:
Theyl producel anl inflammatoryl responsel tol decreasel pregnancy.
QUESTION
Whatl isl thel lifespanl ofl copperl devicesl usedl forl contraception?
Answer:
10l years.
QUESTION
Whatl isl thel lifespanl ofl hormonel devicesl usedl forl contraception?
Answer:
3-5l years.
,QUESTION
Whatl arel thel benefitsl ofl usingl hormonall contraceptives?
Answer:
Highlyl effective,l lastsl 5-10l years,l andl reducesl menstruall flow.
QUESTION
Whatl isl Depotl Medroxyprogesteronel Acetatel (DMPA)l commonlyl knownl as?
Answer:
Depo-Provera.
QUESTION
Whatl arel thel primaryl actionsl ofl Depo-Provera?
Answer:
Preventsl LH,l inhibitsl ovulation,l thickensl cervicall mucus,l andl causesl endometriall atrophy.
QUESTION
Whatl isl al significantl sidel effectl ofl Depo-Provera?
Answer:
Lossl ofl bonel minerall densityl (blackl boxl warning;l avoidl usel forl morel thanl 2l years)l
andl delayedl returnl ofl fertility.
QUESTION
Whatl isl thel durationl ofl effectivenessl forl Depo-Provera?
Answer:
Lastsl 3l months.
QUESTION
, Whatl isl thel agel rangel forl bienniall mammographyl screeningl forl womenl atl averagel risk?
Answer:
Agesl 50-74l years.
QUESTION
Whatl typel ofl mammographyl screeningl isl recommendedl forl womenl agesl 40-49l withl
averagel risk?
Answer:
Individualizedl mammographyl screening.
QUESTION
Whatl isl thel recommendationl regardingl breastl self-examsl forl womenl ofl anyl age?
Answer:
Insufficientl evidencel tol recommendl duel tol associatedl risks.
QUESTION
Atl whatl agel shouldl cervicall screeningl start?
Answer:
Agel 21.
QUESTION
Whatl isl thel cervicall cytologyl screeningl recommendationl forl womenl agesl 21-65?
Answer:
Everyl 3l years.
QUESTION
Isl HPVl co-testingl recommendedl forl womenl underl 30?
